Positive Results of EndoBarrier Therapy for Obesity, Diabetes, Presented at Digestive Disease Week
News
GI Dynamics, of Lexington, Massachusetts, and Sydney, Australia, recently announced the results of clinical studies with their lead therapy, EndoBarrier for obesity and type 2 diabetes. Researchers presented results of the studies during the ... Read more